Skip to content

H&F Corporate Investors X, Ltd.

Follow

13F filer, CIK 1901930, San Francisco, CA

H&F Corporate Investors X, Ltd. reported $2,795,283,417 across 1 holding for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-345867

Period
2026-06-30
Reported value
$2.8B
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MDLNreduced-15,599,171-$615M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001193125-26-345867, largest first. % of portfolio is the value over $2,795,283,417, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 99,514,069 shares; 2026Q1: 86,473,497 shares; 2026Q2: 70,874,326 shares 70,874,326$2.8B100%-15,599,171Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-345867 base2026-08-12acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001193125-26-345867 Quarter ended 2026-06-302026-08-12acceptance time not in the bulk data set
13F-HR 0001193125-26-217059 Quarter ended 2026-03-312026-05-11acceptance time not in the bulk data set
13F-HR 0001193125-26-051633 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001193125-25-276837 Quarter ended 2025-09-302025-11-12acceptance time not in the bulk data set
13F-HR 0000950123-25-007590 Quarter ended 2025-06-302025-08-12acceptance time not in the bulk data set
13F-HR 0000950123-25-004981 Quarter ended 2025-03-312025-05-13acceptance time not in the bulk data set
13F-HR 0000950123-25-001809 Quarter ended 2024-12-312025-02-12acceptance time not in the bulk data set
13F-HR 0000950123-24-011166 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR 0000950123-24-008669 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000950123-24-004595 Quarter ended 2024-03-312024-05-13acceptance time not in the bulk data set
13F-HR 0000950123-24-001946 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0000950123-23-009971 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0000950123-23-007425 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0000950123-23-003767 Quarter ended 2023-03-312023-05-04acceptance time not in the bulk data set
13F-HR 0000950123-23-000464 Quarter ended 2022-12-312023-01-30acceptance time not in the bulk data set
13F-HR 0000950123-22-011887 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0000950123-22-008073 Quarter ended 2022-06-302022-08-09acceptance time not in the bulk data set
13F-HR 0000950123-22-006243 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set